Molecular diagnostics: build nucleic-acid recovery, amplification setup and contamination control into fluidics

01Which branches make up molecular-diagnostic fluidics?

Map sample, common reagent, nucleic-acid eluate and waste paths first, then assign supply, pipetting and bead-handling actions. Draw washing stations and waste branches separately, including maintenance bypasses.

02Common product roles and application guides

Provide FOREACH with the following task boundaries to match configurations. Component categories indicate candidate roles; final models require actual liquids, operating points and instrument tests. HMD syringe pumps use solenoid-valve routing and offer single or multiple metering channels; HLD3/HLD6 use rotary-valve routing with one metering unit. Distinguish multiple selectable paths from simultaneous multichannel metering.^[4][5]

03Operating conditions to confirm at each stage

Selection inputs must describe specific actions; 'for nucleic-acid extraction' is insufficient to determine pump or valve suitability.

04Lysis and reagent preparation: configure for actual formulations

For reagents containing salts, ethanol or other organic components, check pump chambers, valve internals, seals and tubing against the actual formulation. Water metering results support only preliminary checks; establish aspiration, dispensing, residence and cleaning conditions separately for real reagents.

Fixed supply suits repeated dispensing of common reagents. Sharing pumps and valves reduces components but requires switching, flushing and cleaning time. Evaluate dedicated channels when cleaning consumption is high, residue is unacceptable or parallel timing is tight. Compare component savings with liquid use, cycle time and maintenance.

Further technical reading

05Separation washing and elution: evaluate actions by nucleic-acid recovery

In tip-pipetting workflows, washing generally retains beads while removing liquid; after elution, the nucleic-acid-containing eluate is transferred. Set aspiration position, speed and magnetic-separation wait separately; similar volumes do not justify reusing the same sequence.

In magnetic-rod workflows, focus shifts to bead collection and release, liquid carried between wells and eluate recovery after final bead removal. Aspiration needs depend on upstream and downstream steps. Longer waits may improve separation but reduce throughput; decide from bead condition, actual residue and recovery rather than extending all waits uniformly.^[1]

Post-wash residue and nucleic-acid loss are different problems. While removing residue, also check the eluate's effect on downstream reactions. When increasing recovery, verify whether more beads or unwanted components are carried along.

Further technical reading

06Valve paths and isolation: define nucleic-acid, reagent and waste directions

Switching valves can serve fixed reagent supply; samples and nucleic-acid eluate need not use the same valve. For shared paths, explain segment by segment why sharing is needed, where residue goes and how cleaning is validated. Check backflow, incorrect switching and maintenance cross-contact between nucleic-acid and waste paths under both normal and fault conditions.

Zoning must cover reagent preparation, sample processing and extraction, template addition, amplification and post-amplification work. At minimum, define pre-/post-amplification isolation, using space, sealed consumables and one-way operations to organize the instrument's paths. Items contacting amplification products and maintenance actions must avoid returning contamination to pre-amplification areas. Filter tips are one measure, not a replacement for path and operational management.^[2]

Further technical reading

07Tubing connections: consider adsorption and complete recovery

When small eluate volumes pass through fixed tubing, connector cavities and tubing hold-up may consume a substantial part of the recoverable volume. Shorter paths reduce hold-up, but excessively small bores increase resistance. Evaluate fittings and tubing together rather than comparing nominal pump accuracy alone.

Chemical resistance and nucleic-acid recovery are separate checks. Compare recovery through the target sample's actual wetted path with reference handling, including connectors, seals and specified residence time. Disposable tips shorten reused wetted paths, but tip material, wall adhesion, residual liquid and assembly sealing still require checking.

Further technical reading

08Fluidic monitoring: associate amplification setup with sample status

Define the order of master-mix aliquoting, template addition and mixing. For enzyme-containing or viscous components, develop aspiration/dispensing sequences at actual operating temperatures and doses, checking aspiration dwell, residual liquid, mixing and foaming. Air-displacement modules can automate tip pipetting, but module functions do not establish that the full assay is compatible.^[3]

Bubble or pressure sensing outputs abnormality signals; the instrument control system then associates them with the current well, liquid type and action. Record commanded volume, action feedback and detection results, distinguishing estimated transfer from measured volume. If an alarm leaves the volume already added to a well uncertain, follow predefined assay handling; simply repeating the action may change reaction ratios.

If tip changes, temperature control or cleaning slow a shared pipetting head, evaluate separate master-mix and template channels. Separate channels still require control of consumables, layout and operating sequence.

Further technical reading

09Explore configurations through product application guides

Use the following questions to choose an evaluation starting point when preparing configuration information:

10Validate the complete cycle through application results

Measure volume, nucleic-acid recovery, inhibition and contamination separately, then relate them to the same complete cycle. One passing negative control shows only that the relevant abnormality was not detected under that control's conditions.

11Common selection and recovery questions

Can washing and elution use the same action settings?

First determine whether the action aspirates liquid or transfers beads, then whether the step must retain beads or nucleic-acid eluate. Set aspiration positions and speeds separately in pipetting workflows; evaluate collection, release and liquid carried with beads separately in magnetic-rod workflows. Relate actions to recovery and residue results.

Does acceptable transfer volume establish acceptable extraction and contamination control?

Volume acceptance covers only metering. Also check nucleic-acid recovery, inhibition, extraction blanks, no-template controls and cross-contamination challenges, including operation, restart and post-maintenance conditions.

Can one valve select reagents, nucleic-acid eluate and waste?

This is not a default configuration. First evaluate separating fixed reagent supply from sample transfer. If sharing is necessary, demonstrate that residue, backflow, cleaning and fault states meet assay requirements.

References